UB
WST icon

UMB Bank’s West Pharmaceutical WST Stock Holding History

UMB Bank’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.34M Sell
3,729
-8
-0.2% -$2.45K 0.02% 323
2026
Q1 		$937K Buy
3,737
+157
+4% +$39.1K 0.01% 370
2025
Q4 		$985K Buy
3,580
+21
+0.6% +$5.74K 0.01% 360
2025
Q3 		$934K Sell
3,559
-32
-0.9% -$7.78K 0.01% 341
2025
Q2 		$786K Sell
3,591
-198
-5% -$42.3K 0.01% 355
2025
Q1 		$848K Sell
3,789
-291
-7% -$80.2K 0.01% 344
2024
Q4 		$1.34M Buy
4,080
+139
+4% +$43.7K 0.02% 286
2024
Q3 		$1.18M Buy
3,941
+47
+1% +$14.4K 0.02% 302
2024
Q2 		$1.28M Buy
3,894
+69
+2% +$24.4K 0.02% 288
2024
Q1 		$1.51M Sell
3,825
-2
-0.1% -$740 0.02% 273
2023
Q4 		$1.35M Sell
3,827
-4
-0.1% -$1.42K 0.02% 298
2023
Q3 		$1.44M Buy
3,831
+15
+0.4% +$5.8K 0.02% 283
2023
Q2 		$1.46M Hold
3,816
– – 0.02% 292
2023
Q1 		$1.32M Buy
3,816
+810
+27% +$237K 0.02% 299
2022
Q4 		$707K Sell
3,006
-781
-21% -$185K 0.01% 377
2022
Q3 		$932K Buy
3,787
+641
+20% +$195K 0.02% 353
2022
Q2 		$952K Buy
3,146
+8
+0.3% +$2.6K 0.01% 377
2022
Q1 		$1.29M Buy
3,138
+1
+0% +$391 0.02% 350
2021
Q4 		$1.47M Buy
+3,137
New +$1.35M 0.02% 345

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

UMB Bank's WST Position: Q2 2026 in Review

UMB Bank reduced its West Pharmaceutical (WST) stake by 0.21% in Q2 2026, selling an estimated $2.45K and leaving 3,729 shares worth $1.34M. The position accounts for 0.02% of the portfolio, ranked #323.

UMB Bank first reported a position in WST in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.51M in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • UMB Bank held 3,729 shares of West Pharmaceutical worth $1.34M as of Q2 2026.
  • UMB Bank sold 8 West Pharmaceutical shares in Q2 2026, an estimated $2.45K.
  • West Pharmaceutical made up 0.02% of UMB Bank's portfolio in Q2 2026, its #323 holding.
  • UMB Bank first reported a position in West Pharmaceutical in Q4 2021 and has held it in 19 quarters since.
  • UMB Bank's West Pharmaceutical position peaked at $1.51M in Q1 2024.
  • 831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on UMB Bank's 13F filing for Q2 2026, filed 13 Aug 2026.